Calif. Board of Pharmacy looks to restrict access to B-12 formulation
The California Board of Pharmacy is looking to restrict access to Category 1 sterile compounds like B-12 shots and glutathione. They're elements that many people with health issues - including Lyme disease, diabetes, and chronic fatigue syndrome - depend on. Many firefighters say these glutathione treatments help them recover after battling wildfires. After significant public backlash, the board is looking to restrict access and require authorization patient by patient.
Top Videos
Calif. Board of Pharmacy looks to restrict access to B-12 formulation
Motorcyclist killed on 405 Freeway in Sherman Oaks
Meta reaches $17B settlement in social media addiction suit
Tim Curry dies at 80
Local fans remember Dolly Parton
Teens attack man in hot tub
Suspected carjacker leads dramatic police chase
OC father of 5 paralyzed after saving child from rip current
'Chucky' mask suspect arrested in Las Vegas
K9 Bolt wins TSA's Cutest Canine contest
US-Canada trade war could drive up prices
Waymo expands in Southern California
'Stop Nick Shirley Act' opponents rally in Sacramento
Coalition demands GKN stops dangerous operations
Meta agrees to settle social media addiction case for up to $16.8B
Warm water brings hammerhead shark to Laguna Beach
Southland temps soar, fire danger rises
Billionaire Druckenmiller warns of US financial trouble
Maintenance work leaves residents without power
First day of school for Long Beach Unified students
9/11 victim ID'd using new genetic genealogy technique
Are we finally ending daylight saving time?
Target apologizes for children's clown Halloween costume
Pedestrian killed in hit-and-run crash in South LA
Extreme heat hits Southern California through Friday
